Wednesday, September 16, 2009 12:43:14 PM
$28.22, which was the high before the recent move up. This is just
technical analysis on the price movement of the stock. I have no
position in MYGN. This seems to have good support at current price of $30.00.
Recent MYGN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 01:18:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:11:41 PM
- Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance • GlobeNewswire Inc. • 11/07/2024 09:05:00 PM
- Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing • GlobeNewswire Inc. • 11/04/2024 01:39:37 PM
- Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024 • GlobeNewswire Inc. • 10/30/2024 12:00:00 PM
- Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access • GlobeNewswire Inc. • 10/16/2024 01:00:00 PM
- Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration • GlobeNewswire Inc. • 10/15/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 09:23:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 02:35:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 08:36:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 08:33:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 08:31:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 10:11:04 AM
- Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer • GlobeNewswire Inc. • 10/08/2024 08:05:00 PM
- Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics • GlobeNewswire Inc. • 10/03/2024 01:00:00 PM
- Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date • GlobeNewswire Inc. • 10/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2024 08:21:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2024 08:17:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2024 08:15:25 PM
- Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference • GlobeNewswire Inc. • 09/18/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 06:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 08:11:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 08:09:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 07:26:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 02:05:08 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM